Sterling Accuris’ revenue surpasses Rs 200 Cr in FY25, turns EBITDA positive

Diagnostic and pathology services chain Sterling Accuris Diagnostics managed 22% year-on-year growth in its operating scale during the fiscal year ending March 2025. Significantly, the Ahmedabad-based firm also narrowed its losses and turned EBITDA positive during the last fiscal year.

The company’s revenue from operations grew to Rs 198 crore in FY25 from Rs 162 crore in FY24, its consolidated financial statements sourced from the Registrar of Companies (RoC) show.

Founded in 2014, Sterling Accuris Diagnostics offers over 2,000 tests through around…